Merck Explores Purchase of Biotech Seagen
Merck & Co. is eyeing a purchase of biotech Seagen according to people familiar with the matter, a move that would beef up the pharmaceutical giant’s cancer-drug portfolio. Talks have…
Merck Explores Purchase of Biotech Seagen
Merck & Co. is eyeing a purchase of biotech Seagen according to people familiar with the matter, a move that would beef up the pharmaceutical giant’s cancer-drug portfolio. Talks have…
FDA Advisers Endorse Pfizer, Moderna Covid-19 Vaccines in Young Children
This copy is for your personal, non-commercial use only. Distribution and use of this material are governed by our Subscriber Agreement and by copyright law. For non-personal use or to…
FDA Should Authorize Moderna’s Vaccine for Ages 6 to 17, Advisers Say
This copy is for your personal, non-commercial use only. Distribution and use of this material are governed by our Subscriber Agreement and by copyright law. For non-personal use or to…
Covid-19 Variant Shot From Sanofi, GSK Shows Strong Response to Omicron in Studies
A Covid-19 vaccine developed by Sanofi SA and GSK PLC to target the Beta strain of the virus produced a stronger antibody response against variants of Omicron when given as…
Three-Dose Pfizer Covid Vaccine Works Safely in Young Children, Review Says
Three doses of the Covid-19 vaccine from Pfizer Inc. and BioNTech SE were effective at preventing symptomatic disease in children ages 6 months through 4 years in studies, according to…
J&J Says It Plans to End Covid-19 Vaccine Supply Deal With Emergent BioSolutions
Johnson & Johnson said Monday it planned to terminate its Covid-19 vaccine supply deal with contract manufacturer Emergent BioSolutions Inc., as both companies accused each other of breaching the agreement.…
Bristol-Myers to Buy Turning Point Therapeutics for $4.1 Billion
Bristol-Myers Squibb said it would acquire biotechnology company Turning Point Therapeutics for $4.1 billion, an effort to deepen the biopharmaceutical giant’s position in lung-cancer treatments. The purchase price of $76…
FDA Approves New Bristol-Myers Drug for Common Inherited Heart Disease
U.S. health regulators approved a pill from Bristol-Myers Squibb Co. that is the first to treat people with the most common genetic heart disease. The Food and Drug Administration cleared…
Amgen Says IRS Seeks $7.1 Billion in Back Taxes, Penalties
Amgen Inc. has been hit with a bill for more than $7 billion in unpaid taxes and penalties from the Internal Revenue Service, the company said Wednesday, the latest salvo…
